KCP
RMD icon

Kera Capital Partners’s ResMed RMD Stock Holding History

Kera Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
2,530
+871
+53% +$181K 0.05% 326
2026
Q1 		$372K Buy
1,659
+818
+97% +$204K 0.05% 341
2025
Q4 		$217K Buy
841
+52
+7% +$13.3K 0.03% 506
2025
Q3 		$216K Buy
+789
New +$216K 0.03% 386

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kera Capital Partners's RMD Position: Q2 2026 in Review

Kera Capital Partners increased its ResMed (RMD) stake by 53% in Q2 2026, buying an estimated $181K and bringing the position to 2,530 shares worth $493K. The position accounts for 0.05% of the portfolio, ranked #326.

Kera Capital Partners first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. 890 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kera Capital Partners held 2,530 shares of ResMed worth $493K as of Q2 2026.
  • Kera Capital Partners bought 871 ResMed shares in Q2 2026, an estimated $181K.
  • ResMed made up 0.05% of Kera Capital Partners's portfolio in Q2 2026, its #326 holding.
  • Kera Capital Partners first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • 890 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.